Literature DB >> 17109214

Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein.

Li Zhang1, Ge Lin, Zhong Zuo.   

Abstract

PURPOSE: The present study aims to investigate the involvement of UDP-glucuronosyltranferase (UGT) in the extensive liver and intestinal first-pass glucuronidation of baicalein (B) in both rats and humans and also to study sulfation and P450 mediated hydroxylation of B.
MATERIALS AND METHODS: B was incubated with liver and intestine microsome, cytosol, S9 fractions from human, rat and various human recombinant UGT isozymes, respectively. The generated metabolites were identified by HPLC/MS/MS and quantified by HPLC/UV.
RESULTS: Three metabolites of B namely baicalein 7-O-glucuronide (BG), the isomer of baicalein 7-O-glucuronide (BG'), and baicalein sulfate were found. BG, the predominant metabolite of B, was extensively generated in liver and jejunum microsomes in both humans and rats. Its formation was mainly catalyzed by UGT 1A9 and also mediated by UGT 1A1, 1A3, 1A8, 1A7 and 2B15 with different kinetic profiles. UGT 1A8 mediated formation of BG' was mainly found in human intestine and rat liver microsomes. Sulfation and P450 mediated hydroxylation of B were much less significant than glucuronidation.
CONCLUSIONS: Extensive liver and intestinal first-pass glucuronidation of B were found in both humans and rats. Under the current experimental conditions, UGT 1A9 and UGT 1A8 demonstrated the fastest formation rate of BG in human liver preparations and BG' in human intestine preparations, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109214     DOI: 10.1007/s11095-006-9126-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  23 in total

1.  Role of intestinal first-pass metabolism of baicalein in its absorption process.

Authors:  Li Zhang; Ge Lin; Qi Chang; Zhong Zuo
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

Review 2.  Inhibition of carcinogenesis by dietary polyphenolic compounds.

Authors:  C S Yang; J M Landau; M T Huang; H L Newmark
Journal:  Annu Rev Nutr       Date:  2001       Impact factor: 11.848

3.  Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells.

Authors:  M Kimata; M Shichijo; T Miura; I Serizawa; N Inagaki; H Nagai
Journal:  Clin Exp Allergy       Date:  2000-04       Impact factor: 5.018

4.  [The chemical structure of new substance as the metabolite of baicalin and time profiles for the plasma concentration after oral administration of sho-saiko-to in human].

Authors:  R Muto; T Motozuka; M Nakano; Y Tatsumi; F Sakamoto; N Kosaka
Journal:  Yakugaku Zasshi       Date:  1998-03       Impact factor: 0.302

5.  Conjugation position of quercetin glucuronides and effect on biological activity.

Authors:  A J Day; Y Bao; M R Morgan; G Williamson
Journal:  Free Radic Biol Med       Date:  2000-12-15       Impact factor: 7.376

6.  Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.

Authors:  Marelle G Boersma; Hester van der Woude; Jan Bogaards; Sjef Boeren; Jacques Vervoort; Nicole H P Cnubben; Marlou L P S van Iersel; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

Review 7.  Pharmacokinetics and metabolism of dietary flavonoids in humans.

Authors:  Claudine Manach; Jennifer L Donovan
Journal:  Free Radic Res       Date:  2004-08

8.  Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake.

Authors:  Nikhil K Basu; Marco Ciotti; Myung S Hwang; Labanyamoy Kole; Partha S Mitra; Jeong W Cho; Ida S Owens
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

9.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands.

Authors:  M G Hertog; P C Hollman; M B Katan; D Kromhout
Journal:  Nutr Cancer       Date:  1993       Impact factor: 2.900

Review 10.  How should we assess the effects of exposure to dietary polyphenols in vitro?

Authors:  Paul A Kroon; Michael N Clifford; Alan Crozier; Andrea J Day; Jennifer L Donovan; Claudine Manach; Gary Williamson
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045

View more
  15 in total

1.  Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae.

Authors:  Chenrui Li; Li Zhang; Limin Zhou; Siu Kwan Wo; Ge Lin; Zhong Zuo
Journal:  AAPS J       Date:  2011-12-14       Impact factor: 4.009

Review 2.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

3.  Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability.

Authors:  Xiuqiong He; Lixia Pei; Henry H Y Tong; Ying Zheng
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

4.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

Authors:  Lan Tang; Ling Ye; Rashim Singh; Baojian Wu; Chang Lv; Jie Zhao; Zhongqiu Liu; Ming Hu
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 5.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

Review 6.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

Review 7.  Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies.

Authors:  Haijun Chen; Yu Gao; Jianlei Wu; Yingyu Chen; Buyuan Chen; Jianda Hu; Jia Zhou
Journal:  Cancer Lett       Date:  2014-08-13       Impact factor: 8.679

8.  Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers.

Authors:  Hongxian Pang; Wei Xue; Aixin Shi; Min Li; Yang Li; Guoying Cao; Bei Yan; Fan Dong; Wei Xiao; Guorong He; Guanhua Du; Xin Hu; Gang Cheng
Journal:  Clin Drug Investig       Date:  2016-09       Impact factor: 2.859

9.  An Agent-Based Approach to Dynamically Represent the Pharmacokinetic Properties of Baicalein.

Authors:  Xiao Zhu; Jianyuan Deng; Zhong Zuo; Tai Ning Lam
Journal:  AAPS J       Date:  2016-08-01       Impact factor: 4.009

10.  Anticancer properties of baicalein: a review.

Authors:  Ying Gao; Shane A Snyder; Jaclyn N Smith; Yi Charlie Chen
Journal:  Med Chem Res       Date:  2016-06-29       Impact factor: 1.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.